1. Home
  2. GRRR vs EDIT Comparison

GRRR vs EDIT Comparison

Compare GRRR & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorilla Technology Group Inc.

GRRR

Gorilla Technology Group Inc.

HOLD

Current Price

$14.02

Market Cap

454.4M

Sector

Technology

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$3.23

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRRR
EDIT
Founded
2001
2013
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
454.4M
432.8M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
GRRR
EDIT
Price
$14.02
$3.23
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.30
AVG Volume (30 Days)
886.1K
2.1M
Earning Date
06-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.50
EPS
N/A
N/A
Revenue
N/A
$31,937,000.00
Revenue This Year
$69.35
N/A
Revenue Next Year
$85.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.64
52 Week Low
$9.04
$1.66
52 Week High
$23.49
$4.54

Technical Indicators

Market Signals
Indicator
GRRR
EDIT
Relative Strength Index (RSI) 48.96 56.64
Support Level $12.19 $2.74
Resistance Level $16.00 $3.21
Average True Range (ATR) 0.88 0.20
MACD 0.23 0.04
Stochastic Oscillator 51.70 69.23

Price Performance

Historical Comparison
GRRR
EDIT

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments. Its expertise lies in revolutionizing urban operations, enhancing security, and optimizing digital transformation. It delivers pioneering products that integrate AI, deep learning, and edge computing to advance intelligent video surveillance, facial recognition, license plate recognition, post-event analytics, cybersecurity, and network intelligence.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: